Troubles for Industry Veteran Diplomat Began Few Years Ago

Diplomat Pharmacy, Inc.’s sale to OptumRx (see story, p. 1) will mark the end of a specialty pharmacy that is nearly half a century old.

Diplomat began operations in 1975 as a small, regional operation, and, in 2014, it made the decision to go public (RSP 7/14, p. 1). At the time, the company was the fourth largest specialty pharmacy in the U.S., and the move was hailed by industry experts. Diplomat made multiple acquisitions to expand into areas such as bleeding disorders, immune globulin therapy and hepatitis C (RSP 7/15, p. 1).

© 2024 MMIT
Angela Maas

Angela Maas

Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy (formerly called Specialty Pharmacy News) since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at HemAware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Contributors:

Peter Johnson,

Leslie Small,

Jinghong Chen,

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
April 11

News Briefs: Amylyx Is Withdrawing ALS Drug Relyvrio in U.S., Canada

READ MORE
fda-approved-rubber-stamp-with-fda-and-pills-on-craft-paper
April 11

New FDA Approvals: FDA Approves BeiGene’s Tevimbra

READ MORE
test-tube
April 11

‘Significant Milestone’ Brings New Weapon to Advanced Melanoma Fight

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today